ACT-774312
ACT-774312 is a potent and selective CRTH2 antagonist with an IC50 of 4 nM. ACT-774312 blocks the activity and internalization of the CRTH2 receptor, and inhibits PGD2-induced morphological changes in eosinophils. ACT-774312 can be used in the research of nasal polyps and type 2 inflammatory diseases.
For research use only. We do not sell to patients.
- CAS No.: 1809863-68-0
- Formula: C18H17ClFN5O2
- Molecular Weight:389.81
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Chemical Information
-
CAS No. 1809863-68-0
-
Molecular Weight 389.81
-
Formula C18H17ClFN5O2
-
SMILES
OC(CN1C2=C(C[C@H](CC2)N(C3=NC=C(Cl)C=N3)C)C4=NC(F)=CC=C41)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Aissaoui H, et al. Design, Synthesis, and Optimization of Indole Acetic Acid Derivatives as Potent and Selective CRTH2 Receptor Antagonists: Discovery of ACT-774312. ChemMedChem. 2023;18(10):e202300007. [Content Brief]
[2]. Géhin M, et al. Pharmacokinetics, pharmacodynamics, tolerability and prediction of clinically effective dose of ACT-774312: A novel CRTH2 antagonist. Basic Clin Pharmacol Toxicol. 2019;124(6):711-721. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)